Showing 5 of 5 recruiting trials for “invasive-mole”
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.
👨⚕️ Manuel Häckl, MD, Basilea Pharmaceutica International Ltd, Allschwil📍 130 sites📅 Started Dec 2024View details ↗
A Trial of Intravenous HRS9432 in the Treatment of Subjects With Candidemia and/or Invasive Candidiasis
RecruitingNCT06456151 ↗
Invasive Candidiasis in Critical Care
Comparison of Uncomplicated Candidemia Therapy Duration in Children
👨⚕️ Brian Fisher, DO, Children's Hospital of Philadelphia📍 17 sites📅 Started Sep 2023View details ↗
Early Discontinuation of Empirical Antifungal Therapy and Biomarkers
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →